Scarica l'app Stockscreener
11.82
6.26%
-0.79
Pre-mercato:
11.49
-0.33
-2.79%
Precedente Chiudi:
$12.61
Aprire:
$11.89
Volume 24 ore:
183.68K
Relative Volume:
0.06
Capitalizzazione di mercato:
$12.31M
Reddito:
-
Utile/perdita netta:
$-1.13M
Rapporto P/E:
-0.2068
EPS:
-57.1626
Flusso di cassa netto:
$-2.63M
1 W Prestazione:
+6.97%
1M Prestazione:
+158.60%
6M Prestazione:
+135.93%
1 anno Prestazione:
-99.20%
Intervallo 1D:
$10.70
$12.47
Intervallo di 1 settimana:
$10.10
$14.54
Portata 52W:
$2.88
$7,200.00
Polyrizon Ltd Stock (PLRZ) Company Profile
Confronta PLRZ con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PLRZ
Polyrizon Ltd
|
11.82 | 13.14M | 0 | -1.13M | -2.63M | -57.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Polyrizon Ltd Borsa (PLRZ) Ultime notizie
Winners Losers: Can Polyrizon Ltd stock attract ESG capital inflows2025 AllTime Highs & Breakout Confirmation Trade Signals - moha.gov.vn
Top Medical Stocks To Keep An Eye OnDecember 2nd - MarketBeat
Resistance Check: Is Polyrizon Ltd stock a buy on dipsShort Setup & Safe Entry Point Identification - moha.gov.vn
Polyrizon completes FDA pre-submission meeting for PL-14 nasal spray - MSN
Polyrizon’s naloxone hydrogel shows positive permeation kinetics - TipRanks
Polyrizon’s intranasal naloxone hydrogel shows promising test results - Investing.com
Polyrizon Unveils Promising Results for Intranasal Naloxone Hydrogel - TipRanks
Polyrizon’s intranasal naloxone hydrogel shows promising test results By Investing.com - Investing.com Canada
Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal Naloxone Hydrogel Program - The Manila Times
Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal ... - Enidnews.com
Polyrizon (Nasdaq: PLRZ) shows rapid permeation in intranasal naloxone hydrogel preclinical studies - Stock Titan
Earnings Update: Is Polyrizon Ltd stock a buy on dipsJuly 2025 Action & Real-Time Stock Price Movement Reports - BỘ NỘI VỤ
Polyrizon Ltd. (PLRZ) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Polyrizon completes FDA pre-submission meeting for allergy blocker - Investing.com
Polyrizon Advances PL-14 Nasal Spray with FDA Meeting - TipRanks
Polyrizon completes FDA pre-submission meeting for allergy blocker By Investing.com - Investing.com India
Polyrizon Completes FDA Pre-Submission Meeting for PL-14 Allergy Blocker Nasal Spray - The Manila Times
Polyrizon completes FDA pre-submission meeting for PL-14 allergy blocker nasal spray - marketscreener.com
Polyrizon Completes FDA Pre-Submission Meeting for PL-14 Allergy Blocker Nasal Spray - GlobeNewswire Inc.
Top Biotech Stocks To ConsiderDecember 4th - MarketBeat
Small Cap Stocks To Keep An Eye OnDecember 4th - MarketBeat
Top Biotech Stocks To Consider – December 4th - Defense World
Biotech Alert: Searches spiking for these stocks today - TipRanks
This Former Penny Stock Just Doubled for the Second Time This Week. Should You Chase the Rally Here? - Barchart.com
Morning Market Movers: SMX, PRAX, PLRZ, RBRK See Big Swings - RTTNews
Polyrizon Ltd. Announces $4.97 Million Securities Offering - TipRanks
We Think Polyrizon (NASDAQ:PLRZ) Can Afford To Drive Business Growth - Yahoo Finance
Top Medical Stocks To Keep An Eye On – December 2nd - Defense World
Polyrizon (PLRZ) Stock Explodes on Naloxone Hydrogel Breakthrough and PL‑14 Upscaling – What Investors Should Know Now - ts2.tech
Polyrizon Surges: A Game-Changer in Progress? - StocksToTrade
Polyrizon (PLRZ) Stock Doubles on Naloxone Hydrogel Breakthrough and PL‑14 Manufacturing Milestone – What Investors Need to Know on December 4, 2025 - ts2.tech
Why Is Polyrizon Stock Skyrocketing Thursday?Polyrizon (NASDAQ:PLRZ) - Benzinga
Polyrizon (NASDAQ: PLRZ) Soars as Superior Mucoadhesion Naloxone Hydrogel Signals Stronger Real-World Opioid Overdose Reversal Potential - Barchart.com
Polyrizon (NASDAQ: PLRZ) Soars as Superior Mucoadhesion - openPR.com
Polyrizon Stock Skyrockets: What Sparked This Surge? - timothysykes.com
From Lab to Global Impact: Polyrizon's Journey to Potentially Redefining Next-Generation Nasal Protection - The Manila Times
Morning Market Movers: PLRZ, PMI, CBIO, HY See Big Swings - RTTNews
Polyrizon (Nasdaq: PLRZ) scales PL-14 nasal spray output for planned 2026 clinical trials - Stock Titan
PLRZ Stock Price and Chart — NASDAQ:PLRZ - TradingView
Why Did Polyrizon Stock Soar Pre-Market Today? - Stocktwits
What Sparked Polyrizon's (PLRZ) 140% After-Hours Stock Surge? - Benzinga
Polyrizon Announces Superior Results for Intranasal Naloxone Hydrogel - TipRanks
PLRZ’s Strategic Moves Spark Investor Curiosity Amid Stock Fluctuations - timothysykes.com
Polyrizon reports positive mucoadhesion results for intranasal naloxone hydrogel - marketscreener.com
Polyrizon’s nasal naloxone gel shows stronger mucoadhesion in study By Investing.com - Investing.com India
Polyrizon Ltd (PLRZ) Stock Soars on Nasal Spray Milestone: Latest News, AI Forecasts and Risk Outlook – December 3, 2025 - ts2.tech
Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone product - The Manila Times
Polyrizon’s nasal naloxone gel shows stronger mucoadhesion in study - Investing.com
Polyrizon (Nasdaq: PLRZ) reports naloxone hydrogel mucoadhesion gains vs approved spray - Stock Titan
Polyrizon Achieves Scaled Manufacturing Milestone for PL-14 Intranasal Allergy Spray - Contract Pharma
S&P 500, NASDAQ and Dow Jones end in green as Wall Street bounces back with Bitcoin boost, Polyrizon rises - The Economic Times
Polyrizon Ltd Azioni (PLRZ) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):